Regulations.gov document
Hospira, Inc. et al.; Withdrawal of Approval of 44 New Drug Applications and 158…
Notice · FDA-2016-N-0002 · posted Feb 13, 2018
Key facts
| Document ID | FDA-2016-N-0002-0048 |
|---|---|
| Title | Hospira, Inc. et al.; Withdrawal of Approval of 44 New Drug Applications and 158 Abbreviated New Drug Applications; Correction |
| Document type | Notice |
| Subtype | Correction |
| Agency | FDA |
| Docket | FDA-2016-N-0002 |
| Posted | Feb 13, 2018 |
| Federal Register citation | 83 FR 6200 |
| FR document number | 2018-02926 |
| Comment period opens | Feb 13, 2018 |
| Effective date | Feb 13, 2018 |
At a glance
- 1–9 Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: